KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Payables (2019 - 2025)

Historic Payables for Hims & Hers Health (HIMS) over the last 7 years, with Q3 2025 value amounting to $198.4 million.

  • Hims & Hers Health's Payables rose 16299.37% to $198.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.4 million, marking a year-over-year increase of 16299.37%. This contributed to the annual value of $91.2 million for FY2024, which is 11170.19% up from last year.
  • Hims & Hers Health's Payables amounted to $198.4 million in Q3 2025, which was up 16299.37% from $105.0 million recorded in Q2 2025.
  • Hims & Hers Health's Payables' 5-year high stood at $198.4 million during Q3 2025, with a 5-year trough of $13.2 million in Q1 2021.
  • Its 5-year average for Payables is $53.8 million, with a median of $38.3 million in 2023.
  • Its Payables has fluctuated over the past 5 years, first soared by 7176922.79% in 2021, then surged by 1677.79% in 2024.
  • Quarter analysis of 5 years shows Hims & Hers Health's Payables stood at $19.6 million in 2021, then soared by 64.78% to $32.4 million in 2022, then soared by 33.08% to $43.1 million in 2023, then surged by 111.7% to $91.2 million in 2024, then surged by 117.61% to $198.4 million in 2025.
  • Its Payables stands at $198.4 million for Q3 2025, versus $105.0 million for Q2 2025 and $108.9 million for Q1 2025.